Updates are available Correction dated 2019-08-29
Click to view Correction: https://doi.org/10.1007/s11864-019-0674-x
-
Authors
Masoud, Sabran J.
Perone, Jennifer A.
Farrow, Norma E.
Mosca, Paul J.
Tyler, Douglas S.
Beasley, Georgia M.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (TL1TR001440)
National Institutes of Health (T32-CA009111)
- License Information
-
More Information
Article History
First Online: 19 September 2018
Change Date: 29 August 2019
Change Type: Correction
Change Details: The original version of this article, which published in <i>Current Treatment Options in Oncology</i>, Volume 19, Issue 11, November 2018, contained an error within the Conflict of Interest statements. It was originally stated that “Norma E. Farrow received support from an NIH T32 grant (T32-CA009111.”
Compliance with Ethical Standards
:
: Sabran J. Masoud received support for travel for the 2018 Melanoma Research Alliance Conference from the PolkaDot Mama Melanoma Research Foundation.Jennifer A. Perone is supported by a Clinical and Translational Science Award Linked Training (TL1) Award from the National Center of Advancing Translational Sciences, National Institutes of Health (NIH) (TL1TR001440).Norma E. Farrow received support from an NIH T32 grant (T32-CA009111).Paul J. Mosca declares that he has no conflict of interest.Douglas S. Tyler declares that he has no conflict of interest.Georgia M. Beasley declares that she has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
